Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Paget

Showing results (41-50 of 50) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 50 results.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|December 7, 2017
Epidemiological and virological assessment of influenza activity in Europe, during the 2004-2005 winterA Meijer, W J Paget, T J Meerhoff, et al.
The Journal of Pharmacology and Experimental Therapeutics|September 1, 1994
Pharmacological characterization of LY293284: A 5-HT1A receptor agonist with high potency and selectivityM M Foreman, R W Fuller, K Rasmussen, et al.
Vaccine|November 30, 2010
Afriflu--international conference on influenza disease burden in Africa, 1-2 June 2010, Marrakech, MoroccoC Steffen, O M Diop, B D Gessner, et al.
Epidemiology and Infection|January 14, 2015
Severely impaired health status of non-notified Q fever patients leads to an underestimation of the true burden of diseaseJ A F van Loenhout, C C H Wielders, G Morroy, et al.
Journal of Medicinal Chemistry|April 1, 1980
Synthesis of syn and anti isomers of 6-[[(hydroxyimino)phenyl]methyl]-1-[(1-methylethyl)sulfonyl]-1H-benzimidazol-2-amine. Inhibitors of rhinovirus multiplicationJ H Wikel, C J Paget, D C DeLong, et al.
Epidemiology and Infection|March 15, 2014
A cross-sectional study to assess the long-term health status of patients with lower respiratory tract infections, including Q feverA S G van Dam, J A F van Loenhout, J B Peters, et al.
BMC Infectious Diseases|July 27, 2021
Evaluation of a standardised protocol to measure the disease burden of respiratory syncytial virus infection in young children in primary careJ J G T van Summeren, C Rizzo, M Hooiveld, et al.
Surgical Endoscopy|May 22, 2020
SAGES primer for taking care of yourself during and after the COVID-19 crisisJonathan Dort, John Romanelli, Nabajit Choudhury, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|November 28, 2009
Oseltamivir-resistant influenza A(H1N1) viruses detected in Europe during season 2007-8 had epidemiologic and clinical characteristics similar to co-circulating susceptible A(H1N1) virusesB C Ciancio, T J Meerhoff, P Kramarz, et al.
Plos One|May 3, 2016
Correction: Temporal Patterns of Influenza A and B in Tropical and Temperate Countries: What Are the Lessons for Influenza Vaccination?S Caini, W Andrade, S Badur, et al.
Pageof 5

Showing results (41-50 of 50) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 50 results.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|December 7, 2017
Epidemiological and virological assessment of influenza activity in Europe, during the 2004-2005 winterA Meijer, W J Paget, T J Meerhoff, et al.
The Journal of Pharmacology and Experimental Therapeutics|September 1, 1994
Pharmacological characterization of LY293284: A 5-HT1A receptor agonist with high potency and selectivityM M Foreman, R W Fuller, K Rasmussen, et al.
Vaccine|November 30, 2010
Afriflu--international conference on influenza disease burden in Africa, 1-2 June 2010, Marrakech, MoroccoC Steffen, O M Diop, B D Gessner, et al.
Epidemiology and Infection|January 14, 2015
Severely impaired health status of non-notified Q fever patients leads to an underestimation of the true burden of diseaseJ A F van Loenhout, C C H Wielders, G Morroy, et al.
Journal of Medicinal Chemistry|April 1, 1980
Synthesis of syn and anti isomers of 6-[[(hydroxyimino)phenyl]methyl]-1-[(1-methylethyl)sulfonyl]-1H-benzimidazol-2-amine. Inhibitors of rhinovirus multiplicationJ H Wikel, C J Paget, D C DeLong, et al.
Epidemiology and Infection|March 15, 2014
A cross-sectional study to assess the long-term health status of patients with lower respiratory tract infections, including Q feverA S G van Dam, J A F van Loenhout, J B Peters, et al.
BMC Infectious Diseases|July 27, 2021
Evaluation of a standardised protocol to measure the disease burden of respiratory syncytial virus infection in young children in primary careJ J G T van Summeren, C Rizzo, M Hooiveld, et al.
Surgical Endoscopy|May 22, 2020
SAGES primer for taking care of yourself during and after the COVID-19 crisisJonathan Dort, John Romanelli, Nabajit Choudhury, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|November 28, 2009
Oseltamivir-resistant influenza A(H1N1) viruses detected in Europe during season 2007-8 had epidemiologic and clinical characteristics similar to co-circulating susceptible A(H1N1) virusesB C Ciancio, T J Meerhoff, P Kramarz, et al.
Plos One|May 3, 2016
Correction: Temporal Patterns of Influenza A and B in Tropical and Temperate Countries: What Are the Lessons for Influenza Vaccination?S Caini, W Andrade, S Badur, et al.
Pageof 5